{"title":"Outcomes of Patients Managed for Wilms’ Tumor at Kenyatta National Hospital, Nairobi Kenya","authors":"A. Rugwe","doi":"10.1016/j.ijrobp.2024.11.032","DOIUrl":null,"url":null,"abstract":"<div><h3>Objectives</h3><div>Wilms' Tumor is a highly curable malignancy with excellent 5 year survival rates of >90% in the developed countries however, the developing countries continue to record dismal survival rates. This is due to late presentations, treatment abandonment and poor healthcare infrastructure .Over time, the developing countries have had better healthcare systems in terms of better imaging and diagnostics, better surgical skills, better access to care and infrastructure.</div><div>This study intended to assess the outcomes of patients managed at Kenyatta National Hospital, Kenya post these advancements</div></div><div><h3>Methods</h3><div>This was retrospective cross-sectional study of 51 patients with Wilms' Tumor diagnosed and treated 1st January 2015 to 31st December 2019 at Kenyatta National Hospital, Kenya. Inclusion criteria: all patients between 0-16 years with Wilms' Tumor. Exclusion criteria: none.</div><div>Data analysis was performed using STATA 11.0 and Kaplan Meier was used to determine the 2 year survival rate</div></div><div><h3>Results</h3><div>The mean age at diagnosis was 4.1.Male and female had an equal distribution. Most common presenting symptom was abdominal distention (which is usually associated with advanced disease).Most common imaging modality used to stage; Abdomen was CT scan and for chest imaging was a chest X-ray .Most patients had favorable histology. SIOP treatment protocol is the most common treatment protocol used.</div><div>Most patients presented with stage III disease(which is an advanced stage) and 98% of the patients studied were alive at 2 years post treatment .</div></div><div><h3>Conclusion</h3><div>Patients are still presenting with late stage disease however our survival rates have greatly improved and is approaching that of the developed countries. SIOP protocol has been adopted by most developing countries.</div></div>","PeriodicalId":14215,"journal":{"name":"International Journal of Radiation Oncology Biology Physics","volume":"121 3","pages":"Page e8"},"PeriodicalIF":6.4000,"publicationDate":"2025-02-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Radiation Oncology Biology Physics","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S036030162403606X","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Objectives
Wilms' Tumor is a highly curable malignancy with excellent 5 year survival rates of >90% in the developed countries however, the developing countries continue to record dismal survival rates. This is due to late presentations, treatment abandonment and poor healthcare infrastructure .Over time, the developing countries have had better healthcare systems in terms of better imaging and diagnostics, better surgical skills, better access to care and infrastructure.
This study intended to assess the outcomes of patients managed at Kenyatta National Hospital, Kenya post these advancements
Methods
This was retrospective cross-sectional study of 51 patients with Wilms' Tumor diagnosed and treated 1st January 2015 to 31st December 2019 at Kenyatta National Hospital, Kenya. Inclusion criteria: all patients between 0-16 years with Wilms' Tumor. Exclusion criteria: none.
Data analysis was performed using STATA 11.0 and Kaplan Meier was used to determine the 2 year survival rate
Results
The mean age at diagnosis was 4.1.Male and female had an equal distribution. Most common presenting symptom was abdominal distention (which is usually associated with advanced disease).Most common imaging modality used to stage; Abdomen was CT scan and for chest imaging was a chest X-ray .Most patients had favorable histology. SIOP treatment protocol is the most common treatment protocol used.
Most patients presented with stage III disease(which is an advanced stage) and 98% of the patients studied were alive at 2 years post treatment .
Conclusion
Patients are still presenting with late stage disease however our survival rates have greatly improved and is approaching that of the developed countries. SIOP protocol has been adopted by most developing countries.
期刊介绍:
International Journal of Radiation Oncology • Biology • Physics (IJROBP), known in the field as the Red Journal, publishes original laboratory and clinical investigations related to radiation oncology, radiation biology, medical physics, and both education and health policy as it relates to the field.
This journal has a particular interest in original contributions of the following types: prospective clinical trials, outcomes research, and large database interrogation. In addition, it seeks reports of high-impact innovations in single or combined modality treatment, tumor sensitization, normal tissue protection (including both precision avoidance and pharmacologic means), brachytherapy, particle irradiation, and cancer imaging. Technical advances related to dosimetry and conformal radiation treatment planning are of interest, as are basic science studies investigating tumor physiology and the molecular biology underlying cancer and normal tissue radiation response.